| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $3.1B | $2.4B | $3.4B | $4.1B | $2.9B | $2.0B | $0.6B | $1.1B |
| Cost of Revenue | $0.2B | $0.1B | $0.2B | $0.4B | $0.4B | $0.2B | $0.0B | $0.2B |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $0.7B | $0.3B | $0.9B | $1.2B | $0.4B | $-0.7B | $-1.8B | $-1.8B |
| EPS (Basic) | $2.76 | $1.10 | $3.61 | $4.79 | $1.65 | $-2.95 | $-7.27 | $-7.15 |
| EPS (Diluted) | $2.74 | $1.09 | $3.57 | $4.69 | $1.61 | $-2.95 | $-7.27 | $-7.15 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $7.4B | $7.3B | $7.2B | $6.6B | $6.7B | $6.1B | $6.6B | $9.7B |
| Current Assets | $0.4B | $0.7B | $0.9B | $0.5B | $0.7B | $0.3B | $0.4B | $0.6B |
| Cash & Equivalents | $0.0B | $0.3B | $0.2B | $0.0B | $0.2B | $0.0B | $0.0B | $0.0B |
| Total Liabilities | $3.1B | $3.4B | $3.4B | $3.7B | $4.6B | $4.5B | $4.3B | $5.6B |
| Current Liabilities | $0.7B | $1.3B | $0.6B | $1.0B | $1.2B | $0.7B | $0.6B | $0.8B |
| Stockholders' Equity | $4.3B | $3.9B | $3.8B | $2.9B | $2.1B | $1.6B | $2.3B | $4.1B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $1.2B | $0.9B | $1.0B | $1.9B | $0.8B | $0.3B | $0.7B | $1.0B |
| Investing Cash Flow | $-0.6B | $-0.6B | $-0.6B | $-0.5B | $-0.4B | $-0.2B | $0.0B | $-0.7B |
| Capital Expenditures | — | — | — | — | — | — | — | $0.0B |
| Financing Cash Flow | $-0.8B | $-0.2B | $-0.2B | $-1.6B | $-0.2B | $-0.1B | $-0.7B | $-0.3B |